Q4 2023 · 13F-HR
Decheng Capital LLCholdings as filed
Filed 2024-02-12 · accession 0001104659-24-014002
$357.9M
Reported value
24
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02083G100 | NVLSEUR | Alpine Immune Sciences, Inc. | $135.0M | 37.7% | 7,083,288 | Common | SOLE |
| 98943L107 | ZNTL | Zentalis Pharmaceuticals Inc. | $31.8M | 8.89% | 2,099,583 | Common | SOLE |
| 69404D108 | PACB | Pacific Biosciences of California, Inc. | $28.8M | 8.06% | 2,940,361 | Common | SOLE |
| 88025u109 | — | 10x Genomics, Inc. | $20.1M | 5.62% | 359,554 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $19.6M | 5.47% | 659,928 | Common | SOLE |
| 03969F109 | RCUS | Arcus Biosciences, Inc | $16.6M | 4.64% | 869,790 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $14.9M | 4.16% | 47,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $14.4M | 4.02% | 1,279,700 | Common | SOLE |
| 452327109 | ILMN | Illumnia, Inc. | $11.3M | 3.15% | 80,859 | Common | SOLE |
| 04016x101 | — | Argenx SE | $10.4M | 2.92% | 27,429 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC(NSM) | $10.2M | 2.86% | 1,370,951 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $8.2M | 2.28% | 65,772 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $7.8M | 2.17% | 850,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HOLDINGS INC(NMS) | $5.7M | 1.60% | 92,196 | Common | SOLE |
| 880881107 | 430 | Terns Pharmaceuticals, Inc. | $4.6M | 1.30% | 714,285 | Common | SOLE |
| 05153U107 | AURA | Aura Biosciences, Inc. | $4.6M | 1.28% | 515,555 | Common | SOLE |
| G10830100 | BYSI | BeyondSpring Inc. | $4.5M | 1.24% | 4,958,143 | Common | SOLE |
| 29446K106 | EQ | Equillium Inc. | $3.2M | 0.90% | 4,447,308 | Common | SOLE |
| 04963C209 | ATRC | AtriCure Inc. | $1.7M | 0.46% | 46,259 | Common | SOLE |
| 229790100 | HLTHQ | Cue Health Inc. | $1.5M | 0.41% | 8,980,909 | Common | SOLE |
| 811292200 | SCYX | Scynexis Inc. | $1.2M | 0.35% | 555,555 | Common | SOLE |
| 00032Q104 | WHWK | Aadi Bioscience, Inc. | $1.1M | 0.30% | 526,329 | Common | SOLE |
| 747324101 | PYXS | Pyxis Oncology, Inc (formerly Apexigen) | $588,258 | 0.16% | 326,810 | Common | SOLE |
| 81663L200 | WGS | GeneDx Holdings Corp. | $284,911 | 0.08% | 103,604 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.